Linda Neuman
Geen lopende functies
Vermogen: 5 195 $ op 30-04-2024
Loopbaan van Linda Neuman
Eerdere bekende functies van Linda Neuman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | 14-04-2023 |
| CATALYST BIOSCIENCES | Hoofd Techniek/Wetenschap/O&O | - | 01-04-2021 |
| ADVERUM BIOTECHNOLOGIES, INC. | Hoofd Techniek/Wetenschap/O&O | 02-10-2017 | 01-11-2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
| PUMA BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
| VIRACTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2016 | - |
Opleiding van Linda Neuman
| Indiana Wesleyan University | Masters Business Admin |
| Southern Illinois University | Undergraduate Degree |
| Siu School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 10 |
Operationeel
| Chief Tech/Sci/R&D Officer | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Linda Neuman
- Ervaring
